This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Apr 15;121(8):1164-7.

doi: 10.1002/cncr.29177. Epub 2014 Dec 23.

Histone deacetylase inhibitors in cancer: what have we learned?

James R Whittle¹, Jayesh Desai

Affiliations

PMID: 25537232
DOI: 10.1002/cncr.29177

Free article

Editorial

Histone deacetylase inhibitors in cancer: what have we learned?

James R Whittle et al. Cancer. 2015.

Free article

. 2015 Apr 15;121(8):1164-7.

doi: 10.1002/cncr.29177. Epub 2014 Dec 23.

Authors

James R Whittle¹, Jayesh Desai

Affiliation

¹ Department of Medical Oncology, Royal Melbourne Hospital, Parkville, Victoria, Australia.

PMID: 25537232
DOI: 10.1002/cncr.29177

No abstract available

PubMed Disclaimer

Comment on

Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma.
Choy E, Flamand Y, Balasubramanian S, Butrynski JE, Harmon DC, George S, Cote GM, Wagner AJ, Morgan JA, Sirisawad M, Mani C, Hornicek FJ, Duan Z, Demetri GD. Choy E, et al. Cancer. 2015 Apr 15;121(8):1223-30. doi: 10.1002/cncr.29175. Epub 2014 Dec 23. Cancer. 2015. PMID: 25536954 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information